Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
JBIO
$15.13
+1.82%
JBIO
· Jade Biosciences, Inc.
$15.13
+0.27 (+1.82%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$962.23M
Shares
63.60M
Volume · Oct 21
932.74K
Avg daily vol (3M)
902.38K
All webcasts
Earnings call · FY2022 Q4
Jade Biosciences, Inc. (JBIO) Q4 2022 Earnings Call
Net income · derived Q4
-$15.02M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 29, 2023 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 29, 2023 · complete as-filed document